Geographic Disparity, Area Poverty, and Human Papillomavirus Vaccination

American Journal of Preventive Medicine

Volumn 38, Issue 5, 2010, Pages 525-533

  Pruitt, Sandi L ^a   Schootman, Mario ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ARTICLE; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCOME; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POPULATION RESEARCH; POVERTY; UNITED STATES; VACCINATION;

ADOLESCENT; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; CENSUSES; FEMALE; GEOGRAPHY; HEALTHCARE DISPARITIES; HUMANS; IMMUNIZATION PROGRAMS; LOGISTIC MODELS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; POVERTY; UNITED STATES;

EID: 77950796243     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amepre.2010.01.018     Document Type: Article

References (55)

1. American Cancer Society. Cancer Facts and Figures 2009 (2009)
2. Saslow D., Runowicz C.D., Solomon D., et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 52 6 (2002) 342-362
3. Benard V.B., Johnson C.J., Thompson T.D., et al. Examining the association between socioeconomic status and potential Human Papillomavirus-associated cancers. Cancer 113 10S (2008) 2910-2918
4. Parikh S., Brennan P., and Boffetta P. Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer 105 5 (2003) 687-691
5. Singh G.K., Miller B.A., Hankey B.F., and Edwards B.K. Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Cancer 101 5 (2004) 1051-1057
6. Ward E., Jemal A., Cokkinides V., et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54 2 (2004) 78-93
7. Watson M., Saraiya M., Benard V., et al. Burden of cervical cancer in the U.S., 1998-2003. Cancer 113 10S (2008) 2855-2864
8. Benjamins M.R., Kirby J.B., and Bond Huie S.A. County characteristics and racial and ethnic disparities in the use of preventive services. Prev Med 39 4 (2004) 704-712
9. Coughlin S.S., Leadbetter S., Richards T., and Sabatino S.A. Contextual analysis of breast and cervical cancer screening and factors associated with healthcare access among U.S. women, 2002. Soc Sci Med 66 2 (2008) 260-275
10. Datta G.D., Colditz G.A., Kawachi I., Subramanian S.V., Palmer J.R., and Rosenberg L. Individual-, neighborhood-, and state-level socioeconomic predictors of cervical carcinoma screening among U.S. black women: a multilevel analysis. Cancer 106 3 (2006) 664-669
11. Nelson D.E., Bolen J., Marcus S., Wells H.E., and Meissner H. Cancer screening estimates for U.S. metropolitan areas. Am J Prev Med 24 4 (2003) 301-309
12. Swan J., Breen N., Coates R.J., Rimer B.K., and Lee N.C. Progress in cancer screening practices in the U.S.: results from the 2000 National Health Interview Survey. Cancer 97 6 (2003) 1528-1540
13. Schootman M., Jeffe D.B., Baker E.A., and Walker M.S. Effect of area poverty rate on cancer screening across U.S. communities. J Epidemiol Community Health 60 3 (2006) 202-207
14. U.S. Food and Drug Administration. FDA licenses new vaccine for prevention of cervical cancer and other diseases in females caused by human papillomavirus. www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108666.htm
15. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., Unger E.R., and Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 56 RR-2 (2007) 1-24
16. Saslow D., Castle P.E., Cox J.T., et al. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin 57 1 (2007) 7-28
17. Advisory Committee on Immunization Practices Vaccines for Children Program. Resolution No010/09-1: Vaccines to prevent Human Papillomavirus. www.cdc.gov/vaccines/programs/vfc/downloads/resolutions/1009hpv-508.pdf
18. Centers for Disease Control and Prevention (CDC). Vaccination coverage among adolescents aged 13-17 years-U.S., 2007. MMWR Morb Mortal Wkly Rep 57 40 (2008) 1100-1103
19. Grant D., Kravitz-Wirtz N., Breen N., Tiro J.A., and Tsui J. One in four California adolescent girls have had human papillomavirus vaccination (2009), University of California Los Angeles Center for Health Policy Research, Los Angeles CA
20. Centers for Disease Control and Prevention (CDC). National, state, and local area vaccination coverage among adolescents aged 13-17 years-U.S., 2008. MMWR Morb Mortal Wkly Rep 58 36 (2009) 997-1001
21. Saslow D., and Wheeler C.M. Human papillomavirus vaccines: who will pay, who will receive, when to administer?. Ethn Dis 17 2S 2 (2007) S2-8-13
22. Lee G.M., Santoli J.M., Hannan C., et al. Gaps in vaccine financing for underinsured children in the U.S. JAMA 298 6 (2007) 638-643
23. National, state, and local area vaccination coverage among children aged 19-35 months-U.S., 2007. MMWR Morb Mortal Wkly Rep 57 35 (2008) 961-966
24. Findley S.E., Irigoyen M., and Stockwell M.S. Changes in childhood immunization disparities between central cities and their respective states, 2000 versus 2006. J Urban Health 86 2 (2008) 183-195
25. Middleman A.B. Race/ethnicity and gender disparities in the utilization of a school-based hepatitis B immunization initiative. J Adolesc Health 34 5 (2004) 414-419
26. Wooten K.G., Luman E.T., and Barker L.E. Socioeconomic factors and persistent racial disparities in childhood vaccination. Am J Health Behav 31 4 (2007) 434-445
27. CDC. 2008 behavioral risk factor surveillance system Survey data (2008), USDHHS, CDC, Atlanta GA
28. CDC. Overview: BRFSS 2008. www.cdc.gov/brfss/technical_infodata/surveydata/2008.htm
29. Brewer N.T., and Fazekas K.I. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 45 2-3 (2007) 107-114
30. Chao C., Slezak J.M., Coleman K.J., and Jacobsen S.J. Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am J Public Health 99 6 (2009) 1137-1142
31. Christian W.J., Christian A., and Hopenhayn C. Acceptance of the HPV vaccine for adolescent girls: analysis of state-added questions from the BRFSS. J Adolesc Health 44 5 (2009) 437-445
32. Hopenhayn C., Christian A., Christian W.J., and Schoenberg N.E. Human papillomavirus vaccine: knowledge and attitudes in two Appalachian Kentucky counties. Cancer Causes Control 18 6 (2007) 627-634
33. Kahn J.A., Rosenthal S.L., Jin Y., Huang B., Namakydoust A., and Zimet G.D. Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstet Gynecol 111 5 (2008) 1103-1110
34. Rosenthal S.L., Rupp R., Zimet G.D., et al. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health 43 3 (2008) 239-245
35. Krieger N., Chen J.T., Waterman P.D., Soobader M.J., Subramanian S.V., and Carson R. Geocoding and monitoring of U.S. socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter? The Public Health Disparities Geocoding Project. Am J Epidemiol 156 5 (2002) 471-482
36. Singh G.K., Miller B.A., Hankey B.F., and Edwards B.K. Area socioeconomic variations in U.S. cancer incidence, mortality, stage, treatment, and survival, 1975-1999 (2003), National Cancer Institute, Bethesda MD Report No.: NIH Publication No. 03-0000
37. Rabash J., Charlton C., Browne W.J., Healy M., and Cameron B. MLwiN Version 2.11 (2009), Centre for Multilevel Modelling, University of Bristol
38. Snijders T.A.B., and Bosker R. Multilevel analysis. An introduction to basic and advanced multilevel modeling (1999), Sage, Thousand Oaks CA
39. CDC. Survey data and documentation: BRFSS weighting formula. www.cdc.gov/BRfss/technical_infodata/weighting.htm
40. Larsen K., and Merlo J. Appropriate assessment of neighborhood effects on individual health: integrating random and fixed effects in multilevel logistic regression. Am J Epidemiol 161 1 (2005) 81-88
41. Larsen K., Petersen J.H., Budtz-Jorgensen E., and Endahl L. Interpreting parameters in the logistic regression model with random effects. Biometrics 56 3 (2000) 909-914
42. CDC. VFC: eligibility criteria. www.cdc.gov/vaccines/programs/vfc/providers/elig-scrn-rec-doc-req.htm
43. Pickett K.E., and Pearl M. Multilevel analyses of neighbourhood socioeconomic context and health outcomes: a critical review. J Epidemiol Community Health 55 2 (2001) 111-122
44. Pruitt S.L., Shim M.J., Mullen P.D., Vernon S.W., and Amick B.C. The association of area socioeconomic status and breast, cervical, and colorectal cancer screening: a systematic review. Cancer Epidemiol Biomarkers Prev 18 10 (2009) 2579-2599
45. Robert S.A. Socioeconomic position and health: the independent contribution of community socioeconomic context. Ann Rev Sociol 25 (1999) 489-516
46. Smith P.J., Chu S.Y., and Barker L.E. Children who have received no vaccines: who are they and where do they live?. Pediatrics 114 1 (2004) 187-195
47. Klug S.J., Hukelmann M., and Blettner M. Knowledge about infection with human papillomavirus: a systematic review. Prev Med 46 2 (2008) 87-98
48. Rothman S.M., and Rothman D.J. Marketing HPV vaccine: implications for adolescent health and medical professionalism. JAMA 302 7 (2009) 781-786
49. Gerend M.A., Lee S.C., and Shepherd J.E. Predictors of human papillomavirus vaccination acceptability among underserved women. Sex Transm Dis 34 7 (2007) 468-471
50. Kahn J.A., Rosenthal S.L., Hamann T., and Bernstein D.I. Attitudes about human papillomavirus vaccine in young women. Int J STD AIDS 14 5 (2003) 300-306
51. De Soto J. Should HPV vaccination be mandatory?. J Fam Pract 56 4 (2007) 267-268
52. Schwartz J.L., Caplan A.L., Faden R.R., and Sugarman J. Lessons from the failure of human papillomavirus vaccine state requirements. Clin Pharmacol Ther 82 6 (2007) 760-763
53. Orenstein W.A., and Hinman A.R. The immunization system in the U.S.-the role of school immunization laws. Vaccine 17 S 3 (1999) S19-S24
54. Morita J.Y., Ramirez E., and Trick W.E. Effect of a school-entry vaccination requirement on racial and ethnic disparities in hepatitis B immunization coverage levels among public school students. Pediatrics 121 3 (2008) e547-e552
55. Katz M.L., Reiter P.L., Kluhsman B.C., et al. Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states. Vaccine 27 24 (2009) 3195-3200